Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 1 to 25 of 1160 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
1160 increased abnormal reproductive system development (MP:0003936) female reproductive organ (UBERON:0003134) 2463: Early vaginal opening
1159 decreased reproductive process (GO:0022414) population of organisms (PCO:0000001) 2462: Yield loss in rice
1158 decreased seed development (GO:0048316) 2461: Reduced, grain filling
1157 decreased growth (GO:0040007) 2460: Reduced, biomass accumulation
1156 decreased carbon fixation (GO:0015977) chloroplast (GO:0009507) 2459: Reduced carbon fixation in Calvin cycle
1155 decreased ATP biosynthetic process (GO:0006754) chloroplast ATP synthase complex (GO:0009544) 2458: Reduced, assimilatory power
1154 decreased photosynthetic electron transport chain (GO:0009767) photosystem II (GO:0009523) 2457: Decreased, electron transport in photosystem II
1153 decreased photosynthesis, light reaction (GO:0019684) photosystem II (GO:0009523) 2456: Photosystem II inhibition
1152 disrupted Abnormality of cellular immune system (HP:0010987) activated CD8-positive, alpha-beta T cell (CL:0000906) 2326: CTL cytotoxic activity disruption
1151 abnormal Abnormality of cellular immune system (HP:0010987) alpha-beta T cell (CL:0000789) 2324: Increased of Treg/Th17 cell ratio
1150 increased Abnormality of cellular immune system (HP:0010987) B7-related protein (PR:000001290) 2323: Over-expression of PD-L1 in cancer cells
1149 increased androgen receptor signaling pathway (GO:0030521) Musculature of female perineum (FMA:264623) 2365: Anogenital distance (AGD), increased
1148 occurrence Amyotrophic lateral sclerosis (HP:0007354) adult central nervous system (UBERON:6003623) 2416: human amyotrophic lateral sclerosis (ALS)
1147 increased protein oxidation (GO:0018158) 1767: Increase, Protein oxidation
1146 increased Hepatic bridging fibrosis (HP:0012852) 2414: COL3A1 Signaling Pathway
1145 increased female gonad development (GO:0008585) immature gonad (UBERON:2005272) 2417: Increased, differentiation to ovaries
1144 increased female sex determination (GO:0030237) population of organisms (PCO:0000001) 2418: Increased, phenotypic female-biased sex ratio
1143 increased female gonad development (GO:0008585) None
1142 increased female gonad development (GO:0008585) female organism (UBERON:0003100) None
1141 increased abnormal reproductive system development (MP:0003936) reproductive organ (UBERON:0003133) 2415: Precocious puberty
1140 increased increased uterus weight (MP:0004904) body of uterus (UBERON:0009853) 2413: Increased, uterine weight
1139 increased increased circulating estradiol level (MP:0005182) 17beta-estradiol (CHEBI:16469) 2294: Plasma estradiol, increased
1138 increased neurotransmitter secretion (GO:0007269) Metastin (CHEBI:80304) 1985: Increased Kisspeptin levels in anteroventral periventricular nucleus (AVPV)
1137 increased regulation of steroid hormone biosynthetic process (GO:0090030) 17beta-estradiol (CHEBI:16469) 2402: Increased, estradiol (E2) production in ovaries
1136 decreased neuropeptide signaling pathway (GO:0007218) Metastin (CHEBI:80304) None